Mission of Cosma S.A.
Our mission is to promote the safe and healthy use of products derived from plant extracts.
Mission of Cosma S.A.
Our mission is to promote the safe and healthy use of products derived from plant extracts, with a particular focus on cannabinoids, offered to our customers as food products, cosmetics, cosmetic and pharmaceutical raw materials, as well as medicinal and veterinary products.
Integrated production chain: We control every stage – from raw material extraction through formulation to the finished product. Thanks to our own production facility, we ensure repeatable quality and full batch traceability.
Regulatory Compliance We operate as a Marketing Authorisation Holder (MAH) with all required certifications and approvals. Our products comply with the pharmaceutical, food, and cosmetic law requirements applicable in Poland and the EU.
Documentation and Quality: We maintain full product and analytical documentation—each batch is covered by laboratory tests confirming its composition, purity, and safety of use.
Partner and patient safety: We approach cooperation responsibly and conservatively. We care about the brand and reputation of our partners, distribution licenses, and the health and trust of our products' end-users.
Medical marijuana
Our mission at Cosma S.A. is to create and deliver hemp products of the highest quality that serve the well-being of our patients, as well as support the further development and establishment of the therapeutic use of hemp in medical practice.
Cosma S.A. strives to provide a wide range of hemp products, from dietary supplements to prescription medicinal products. We are convinced that Polish patients deserve access to a diverse range of products that meet the highest standards.
Our portfolio is carefully composed on the basis of dried plants and plant extracts. All our products undergo rigorous testing, which includes analysis of chemical and terpene profiles, in accordance with the strict requirements of European legislation.
We believe that having a wide range of products - with different levels of THC, CBD, CBG, as well as terpenes - is key to advancing the therapeutic use of cannabis. We aim to increase patient safety by providing products with proven efficacy, as well as to support doctors in making informed and responsible therapeutic decisions.
Plant extracts
Over the past decade, interest in plant extracts in Europe has grown significantly. As the leader in the global essential oil market, Europe has recorded a market value of $3.9 billion in 2020. The European market is expected to grow even faster in the coming years, with an annual growth rate of 9.6% from 2022 to 2029.
Imports of essential oils into the EU rose by an average of about 3% annually between 2017 and 2021, a trend driven by growing awareness of mental health issues and a rising preference for natural alternatives to pharmaceutical drugs
The market for European plant extracts is expected to grow by 7.1% per year between 2021 and 2028, reaching $5.991 million by 20281. Cosma S.A. is poised to meet this growing demand by offering extracts that are useful in a variety of sectors - from food and cosmetics to feed production.
In 2021, European imports of plant extracts totaled over 77,000 metric tons, representing an annual increase of 8% since 2017. Recognizing the growing interest in plant extracts, Cosma S.A. is committed to supplying these valuable raw materials to the food, cosmetics, and animal feed sectors. We are working on the production of plant extracts using the CO2 extraction method. This advanced technology allows for the production of high-purity extracts with concentrated potency. We aim to deliver dense or standardized extracts tailored to the needs of industrial clients.